Voilà!™ Rapid Digital
SARS-CoV-2 Saliva Test

voila application in


Voilà!™ SARS-CoV-2 is our rapid and digital antigen COVID-19 testing solution. Combining Lateral Flow Immunoassay (LFIA) and digital technologies, the qualitative detection of the nucleocapsid protein from SARS-CoV-2 in saliva samples is displayed to your smartphone within minutes. Test results can be viewed by connecting via Bluetooth to the complementary Voilà! mobile app and sent to the cloud for integration with our software. The fluorescent nanoparticles and optical micro sensor enable our test to detect lower levels of the antigen.

This product is for Performance Evaluation and Investigational Use only. The performance characteristics of this product have not been established. All performance claims and dates listed are project goals only. Such forward-looking statements are based on the expectations of the management of the company.